AKT2 anticorps (N-Term)

N° du produit ABIN926888

L’anticorps anti-AKT2 Polyclonal Lapin est utilisé pour la détection de AKT2 dans des échantillons de Humain, Souris, Rat, Chien et Boeuf (Vache). Il a été validé pour WB.

Aperçu rapide pour AKT2 anticorps (N-Term) (ABIN926888)

Antigène: AKT2 (V-Akt Murine Thymoma Viral Oncogene Homolog 2 (AKT2))

Reactivité: Humain, Souris, Rat, Chien, Boeuf (Vache)

Hôte: Lapin

Clonalité: Polyclonal

Conjugué: Cet anticorp AKT2 est non-conjugé

Application: Western Blotting (WB)

Détail du produit anti-AKT2 anticorps

Épitope: N-Term

Réactivité croisée: Souris, Rat (Rattus), Boeuf (Vache), Chien

Purification: Purified

Immunogène: AKT2 antibody was raised in rabbit using the N terminal of AKT2 as the immunogen

Information d'application

Indications d'application: WB: 0.2-1 µg/mL
Optimal conditions should be determined by the investigator.

Commentaires:

AKT2 Blocking Peptide, , is also available for use as a blocking control in assays to test for specificity of this AKT2 antibody

Restrictions: For Research Use only

Stockage

Format: Lyophilized

Concentration: Lot specific

Buffer: Lyophilized powder. Add 50 µL of distilled water. Final antibody concentration is 1 mg/mL in PBS buffer.

Conseil sur la manipulation: Avoid repeated freeze/thaw cycles.

Stock: 4 °C/-20 °C

Stockage commentaire: Store at 4 °C, following reconstitution, aliquot and store at -20 °C.

Détails sur AKT2

Antigène: AKT2 (V-Akt Murine Thymoma Viral Oncogene Homolog 2 (AKT2))

Autre désignation: AKT2

Sujet: AKT2 belonging to a subfamily of serine/threonine kinases containing SH2-like (Src homology 2-like) domains. The gene encoding AKT2 was shown to be amplified and overexpressed in 2 of 8 ovarian carcinoma cell lines and 2 of 15 primary ovarian tumors. Synonyms: Polyclonal AKT2 antibody, Anti-AKT2 antibody, v-akt murine thymoma viral oncogene homolog 2 antibody, PKBBETA antibody, PRKBB antibody, RAC-BETA antibody.

Pathways: Signalisation PI3K-Akt, Signalisation RTK, AMPK Signaling, Signalisation TLR, Cellular Glucan Metabolic Process, Regulation of Carbohydrate Metabolic Process, Hepatitis C, VEGF Signaling